GlassScriptPhysician profile
Paul Robert Shamirian
NPI 1730541988
$1,965.25
in general payments reported to CMS, 2019-2025
10 companies · $271 in 2025
The $271 reported for 2025 was more than what 82% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.47 · 2020: $111 · 2021: $13.52 · 2022: $353 · 2023: $1,106 · 2024: $19.59 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823 · Travel and Lodging: $496 · Consulting Fee: $75.00 · Gift: $4.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.63 |
| Travel and Lodging | $495.51 |
| Consulting Fee | $75.00 |
| Gift | $4.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,182.69 | 2019-2025 | Invisalign, Itero, Maob |
| American Orthodontics Corporation | $368.76 | 2022-2025 | Master Series, Empower-Metal, Radiance |
| Straumann USA LLC | $121.00 | 2025 | |
| Kerr Corporation | $82.78 | 2023 | Endodontics |
| Nobel Biocare USA | $82.77 | 2023 | Nobelactive |
| USA Angelalign Technology Corp | $37.09 | 2024-2025 | |
| 3m Company | $35.31 | 2019 | |
| Dentsply Sirona Orthodontics INC | $24.16 | 2019 | |
| Lightforce Orthodontics, INC. | $17.17 | 2023 | |
| Ormco Corporation | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Shamirian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.